Caspofungin acetate
| Title | Journal |
|---|---|
| Azole resistance in canine and feline isolates of Aspergillus fumigatus. | Comparative immunology, microbiology and infectious diseases 20151001 |
| Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis. | Chemical research in toxicology 20150518 |
| Activities of fluconazole, caspofungin, anidulafungin, and amphotericin B on planktonic and biofilm Candida species determined by microcalorimetry. | Antimicrobial agents and chemotherapy 20140501 |
| Killing rates exerted by caspofungin in 50 % serum and its correlation with in vivo efficacy in a neutropenic murine model against Candida krusei and Candida inconspicua. | Journal of medical microbiology 20140201 |
| In vitro pharmacodynamics and in vivo efficacy of fluconazole, amphotericin B and caspofungin in a murine infection by Candida lusitaniae. | International journal of antimicrobial agents 20140201 |
| Efficacy of the combination of voriconazole and caspofungin in experimental pulmonary aspergillosis by different Aspergillus species. | Mycopathologia 20140101 |
| Comparative in vitro fungicidal activity of echinocandins against Candida albicans in peritoneal dialysis fluids. | Mycoses 20131101 |
| Mechanism of action of novel synthetic dodecapeptides against Candida albicans. | Biochimica et biophysica acta 20131101 |
| Susceptibility profile of a Brazilian yeast stock collection of Candida species isolated from subjects with Candida-associated denture stomatitis with or without diabetes. | Oral surgery, oral medicine, oral pathology and oral radiology 20131101 |
| Isolation, structure, and biological activity of Phaeofungin, a cyclic lipodepsipeptide from a Phaeosphaeria sp. Using the Genome-Wide Candida albicans Fitness Test. | Journal of natural products 20130322 |
| Posaconazole exhibits in vitro and in vivo synergistic antifungal activity with caspofungin or FK506 against Candida albicans. | PloS one 20130101 |
| The nonsteroidal antiinflammatory drug diclofenac potentiates the in vivo activity of caspofungin against Candida albicans biofilms. | The Journal of infectious diseases 20121201 |
| Heat shock protein 90 is required for conidiation and cell wall integrity in Aspergillus fumigatus. | Eukaryotic cell 20121101 |
| Mutual influence of backbone proline substitution and lipophilic tail character on the biological activity of simplified analogues of caspofungin. | Organic & biomolecular chemistry 20121007 |
| First case of breakthrough pneumonia due to Aspergillus nomius in a patient with acute myeloid leukemia. | Medical mycology 20121001 |
| [Trends in systemic antifungal use in critically ill patients. Multicenter observational study, 2006-2010]. | Enfermedades infecciosas y microbiologia clinica 20121001 |
| β(1,3)-glucan synthase complex from Alternaria infectoria, a rare dematiaceous human pathogen. | Medical mycology 20121001 |
| Comparison of in vitro and vivo efficacy of caspofungin against Candida parapsilosis, C. orthopsilosis, C. metapsilosis and C. albicans. | Mycopathologia 20121001 |
| CRS-MIS in Candida glabrata: sphingolipids modulate echinocandin-Fks interaction. | Molecular microbiology 20121001 |
| Interactions of liposome carriers with infectious fungal hyphae reveals the role of β-glucans. | Molecular pharmaceutics 20120904 |
| Successful treatment of cutaneous alternariosis with caspofungin in a renal transplant recipient. | Mycoses 20120901 |
| Echinocandin resistance due to simultaneous FKS mutation and increased cell wall chitin in a Candida albicans bloodstream isolate following brief exposure to caspofungin. | Journal of medical microbiology 20120901 |
| [Fungal infection secondary to treatment of Escherichia coli in a critically ill patient]. | Ugeskrift for laeger 20120827 |
| Plasma concentrations of caspofungin at two different dosage regimens in a patient with hepatic dysfunction. | Transplant infectious disease : an official journal of the Transplantation Society 20120801 |
| Fatal bronchial invasion of Scopulariopsis brevicaulis in an acute monocytic leukemia patient. | Diagnostic microbiology and infectious disease 20120801 |
| Synthesis and antifungal activities of glycosylated derivatives of the cyclic peptide fungicide caspofungin. | ChemMedChem 20120801 |
| Histoplasmosis in HIV-positive patients in Ceará, Brazil: clinical-laboratory aspects and in vitro antifungal susceptibility of Histoplasma capsulatum isolates. | Transactions of the Royal Society of Tropical Medicine and Hygiene 20120801 |
| A prospective, randomized study of empirical antifungal therapy for the treatment of chemotherapy-induced febrile neutropenia in children. | British journal of haematology 20120701 |
| Breakthrough trichosporonosis in patients receiving echinocandins: case report and literature review. | Chinese medical journal 20120701 |
| Comparison of the Etest and a rapid flow cytometry-based method with the reference CLSI broth microdilution protocol M27-A3 for the echinocandin susceptibility testing of Candida spp. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20120601 |
| Minimal inhibitory concentration (MIC) of caspofungin and itraconazole inhibiting growth of Candida strains calculated from the linear regression equation. | Advances in medical sciences 20120601 |
| Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents. | The Kaohsiung journal of medical sciences 20120601 |
| Hepatic safety of caspofungin during treatment of invasive fungal diseases in elderly patients. | Chinese medical journal 20120601 |
| In vitro and in vivo susceptibility of two-drug and three-drug combinations of terbinafine, itraconazole, caspofungin, ibuprofen and fluvastatin against Pythium insidiosum. | Veterinary microbiology 20120525 |
| Pharmacoeconomic analysis of voriconazole vs. caspofungin in the empirical antifungal therapy of febrile neutropenia in Australia. | Mycoses 20120501 |
| The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates. | Memorias do Instituto Oswaldo Cruz 20120501 |
| Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata. | PLoS pathogens 20120501 |
| Vacuolar H(+)-ATPase plays a key role in cell wall biosynthesis of Aspergillus niger. | Fungal genetics and biology : FG & B 20120401 |
| Breakthrough invasive mould infections in patients treated with caspofungin. | The Journal of infection 20120401 |
| Total synthesis and structure-activity relationships of new echinocandin-like antifungal cyclolipohexapeptides. | European journal of medicinal chemistry 20120401 |
| Caspofungin for prophylaxis and treatment of fungal infections in adolescents and adults: a meta-analysis of randomized controlled trials. | Die Pharmazie 20120401 |
| Pseudomembranous necrotizing tracheobronchial aspergillosis: an analysis of 16 cases. | Chinese medical journal 20120401 |
| Use of antifungal agents in pediatric and adult high-risk areas. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20120301 |
| [Study on in vitro susceptibility of Candida spp. isolated from blood culture]. | Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20120301 |
| A randomized, double-blind, prospective study of caspofungin vs. amphotericin B for the treatment of invasive candidiasis in newborn infants. | Journal of tropical pediatrics 20120201 |
| Antifungal susceptibility of ocular fungal pathogens recovered from around the world against itraconazole, voriconazole, amphotericin B, and caspofungin. | Medical mycology 20120201 |
| The reversed halo sign as the initial radiographic sign of pulmonary zygomycosis. | Infection 20120201 |
| Long-term treatment of invasive sinus, tracheobroncheal, pulmonary and intracerebral aspergillosis in acute lymphoblastic leukaemia. | Infection 20120201 |
| Multiple subcutaneous cysts due to Exophiala spinifera in an immunocompetent patient. | Medical mycology 20120201 |
| Outbreak of invasive aspergillosis after major heart surgery caused by spores in the air of the intensive care unit. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120201 |
| Effect of nikkomycin Z and 50% human serum on the killing activity of high-concentration caspofungin against Candida species using time-kill methodology. | Journal of chemotherapy (Florence, Italy) 20120201 |
| Caspofungin: when and how? The microbiologist's view. | Mycoses 20120101 |
| Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms. | Mycoses 20120101 |
| Broth microdilution and time-kill testing of Caspofungin, voriconazole, amphotericin B and their combinations against clinical isolates of Candida krusei. | Mycopathologia 20120101 |
| Antifungal management and resource use in patients with acute myeloid leukaemia after chemotherapy--retrospective analysis of changes over 3 yr in a German hospital. | European journal of haematology 20120101 |
| Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis. | Journal of clinical pathology 20120101 |
| Role of caspofungin in restoring the impaired phagocyte-dependent innate immunity towards Candida albicans in chronic haemodialysis patients. | International journal of antimicrobial agents 20120101 |
| Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center. | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20120101 |
| [Cost analysis of 3 candins in the treatment of invasive candidiasis in adult non-neutropaenic patients in Spain]. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20120101 |
| Echinocandin use in the neonatal intensive care unit. | The Annals of pharmacotherapy 20120101 |
| Disseminated candidemia refractory to caspofungin therapy in an infant with extremely low birth weight. | Journal of the Formosan Medical Association = Taiwan yi zhi 20120101 |
| Peptides of the constant region of antibodies display fungicidal activity. | PloS one 20120101 |
| Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry. | European journal of medical research 20120101 |
| Microcolony imaging of Aspergillus fumigatus treated with echinocandins reveals both fungistatic and fungicidal activities. | PloS one 20120101 |
| Comparison of the kidney fungal burden in experimental disseminated candidiasis by species of the Candida parapsilosis complex treated with fluconazole, amphotericin B and caspofungin in a temporarily neutropenic murine model. | Chemotherapy 20120101 |
| Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis. | BMC infectious diseases 20120101 |
| [Could antifungal lock be useful in the management of candidiasis linked with catheters?]. | Medecine sciences : M/S 20120101 |
| Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae. | PloS one 20120101 |
| [Adequate empiric therapy of nosocomial fungal infections in oncologic patients of intensive care units]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20120101 |
| Successful treatment of liver aspergilloma by caspofungin acetate first-line therapy in a non-immunocompromised patient. | International journal of molecular sciences 20120101 |
| Fatal post-operative Trichoderma longibrachiatum mediastinitis and peritonitis in a paediatric patient with complex congenital cardiac disease on peritoneal dialysis. | Journal of medical microbiology 20111201 |
| Treatment of chronic pulmonary blastomycosis with caspofungin. | Journal of medical microbiology 20111201 |
| Overview of safety experience with caspofungin in clinical trials conducted over the first 15 years: a brief report. | International journal of antimicrobial agents 20111201 |
| Fungicidal activity of the human peptide hepcidin 20 alone or in combination with other antifungals against Candida glabrata isolates. | Peptides 20111201 |
| Efg1 Controls caspofungin-induced cell aggregation of Candida albicans through the adhesin Als1. | Eukaryotic cell 20111201 |
| Lack of response in severe pneumocystis pneumonia to combined caspofungin and clindamycin treatment: a case report. | Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih 20111201 |
| [Echinocandins]. | Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia 20111201 |
| An on-line solid phase extraction procedure for the routine quantification of caspofungin by liquid chromatography-tandem mass spectrometry. | Clinical chemistry and laboratory medicine 20111130 |
| Successful treatment with echinocandin in an HIV-infected individual failing first-line therapy for Pneumocystis jirovecii pneumonia. | AIDS (London, England) 20111113 |
| Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis. | Medical mycology 20111101 |
| Efficacy and safety of micafungin for treatment of serious Candida infections in patients with or without malignant disease. | Mycoses 20111101 |
| Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland. | Mycopathologia 20111101 |
| In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods. | Antimicrobial agents and chemotherapy 20111101 |
| In vitro effectiveness of antifungal lock solutions on catheters infected with Candida species. | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20111001 |
| Efficacy and safety of caspofungin in obese patients. | Medical mycology 20111001 |
| In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method. | Diagnostic microbiology and infectious disease 20111001 |
| In vitro interaction of caspofungin and immunosuppressives against agents of mucormycosis. | The Journal of antimicrobial chemotherapy 20111001 |
| Post-antifungal effects and time-kill studies of anidulafungin, caspofungin, and micafungin against Candida glabrata and Candida parapsilosis. | Diagnostic microbiology and infectious disease 20111001 |
| Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United States. | Mycoses 20110901 |
| Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin. | Journal of medical microbiology 20110901 |
| Successful treatment of central venous catheter infection due to Candida lipolytica by caspofungin-lock therapy. | Mycoses 20110901 |
| Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes. | The Journal of antimicrobial chemotherapy 20110901 |
| A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study). | The Journal of antimicrobial chemotherapy 20110901 |
| The evaluation of in vitro pharmacodynamic properties of amphotericin B, voriconazole and caspofungin against A. fumigatus isolates by the conventional and colorimetric time-kill assays. | Medical mycology 20110801 |
| Pga26 mediates filamentation and biofilm formation and is required for virulence in Candida albicans. | FEMS yeast research 20110801 |
| A novel assay of biofilm antifungal activity reveals that amphotericin B and caspofungin lyse Candida albicans cells in biofilms. | Yeast (Chichester, England) 20110801 |
| [Outcome analysis of caspofungin in combination with voriconazole for treatment of 12 hematologic malignancies cases with invasive fungal infection]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20110801 |
| Rhodotorula mucilaginosa catheter-related fungaemia in a patient with multiple myeloma. | Mycoses 20110701 |
| Invasive aspergillosis caused by Aspergillus terreus in a living donor liver transplant recipient successfully treated by caspofungin. | Mycoses 20110701 |
| Fungicidal activity and morphological alterations of Candida albicans induced by echinocandins: study of strains with reduced caspofungin susceptibility. | Mycoses 20110701 |
| Retrospective evaluation of caspofungin therapy in invasive aspergillosis (RECAM-IA). | Mycoses 20110701 |
| Intraocular caspofungin: in vitro safety profile for human ocular cells. | Mycoses 20110701 |
| A Candida albicans strain with high MIC for caspofungin and no FKS1 mutations exhibits a high chitin content and mutations in two chitinase genes. | Medical mycology 20110701 |
| Economic evaluation of caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia in Sweden. | Scandinavian journal of infectious diseases 20110701 |
| Pharmacokinetics of caspofungin in a critically ill patient with liver cirrhosis. | European journal of clinical pharmacology 20110701 |
| [Diagnosis and treatment of pneumocystis jirovecii pneumonia]. | Deutsche medizinische Wochenschrift (1946) 20110701 |
| Aspergillus fumigatus joint infection: a review. | Seminars in arthritis and rheumatism 20110601 |
| A trial of caspofungin salvage treatment in PCP pneumonia. | Thorax 20110601 |
| Antifungal susceptibility of bloodstream Candida isolates in Sfax hospital: Tunisia. | Mycopathologia 20110601 |
| Candida utilis candidaemia in neonatal patients. | Journal of medical microbiology 20110601 |
| Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. | Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 20110601 |
| Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus. | The Journal of antimicrobial chemotherapy 20110601 |
| Calcineurin controls drug tolerance, hyphal growth, and virulence in Candida dubliniensis. | Eukaryotic cell 20110601 |
| Selection of resistant fungi in liver transplant recipients during use of newer antifungal agents -- a report of two cases. | Annals of the Academy of Medicine, Singapore 20110601 |
| An accidental mass. | Lancet (London, England) 20110521 |
| A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections. | Mycoses 20110501 |
| European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update. | Bone marrow transplantation 20110501 |
| Breakthrough Saprochaete capitata infections in patients receiving echinocandins: case report and review of the literature. | Medical mycology 20110501 |
| Invasive aspergillosis in patients with liver disease. | Medical mycology 20110501 |
| In vitro interaction of itraconazole with amphotericin B, caspofungin, and terbinafine against clinical isolates of Trichosporon asahii. | Mycopathologia 20110501 |
| [Fatal outcome of invasive tracheal aspergillosis]. | RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 20110501 |
| Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study. | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20110501 |
| Treatment of Alternaria keratitis with intrastromal and topical caspofungin in combination with intrastromal, topical, and oral voriconazole. | The Annals of pharmacotherapy 20110501 |
| Scopulariopsis brevicaulis abscess in a child treated for myeloblastic leukaemia. | The Lancet. Infectious diseases 20110501 |
| [Echinocandins in children]. | Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20110501 |
| Catheter-associated aspergillosis of the chest wall following allogeneic hematopoietic stem cell transplantation. | Transplant infectious disease : an official journal of the Transplantation Society 20110401 |
| Aspergillus thyroiditis in a renal transplant recipient mimicking subacute thyroiditis. | Transplant infectious disease : an official journal of the Transplantation Society 20110401 |
| In vitro interactions among echinocandins against Aspergillus fumigatus: lack of concordance among methods. | Medical mycology 20110401 |
| Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. | Critical care medicine 20110401 |
| Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis. | Antimicrobial agents and chemotherapy 20110401 |
| Comparative in vitro susceptibility of clinical isolates of Candida paparsilosis complex and other Candida species to caspofungin and anidulafungin by Etest. | Journal of chemotherapy (Florence, Italy) 20110401 |
| Efficacy of a single 6 mg/kg versus two 3 mg/kg caspofungin doses for treatment of disseminated candidiasis caused by Candida albicans in a neutropenic mouse model. | Journal of chemotherapy (Florence, Italy) 20110401 |
| Antifungal use in hospitalized adults in U.S. academic health centers. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110301 |
| Caspofungin therapy in immunocompromised children and neonates. | Expert review of anti-infective therapy 20110301 |
| In vitro activity of echinocandins against non-Candida albicans: is echinocandin antifungal activity the same? | Enfermedades infecciosas y microbiologia clinica 20110301 |
| [Combination therapy for invasive aspergillosis]. | Enfermedades infecciosas y microbiologia clinica 20110301 |
| Linezolid and clindamycin improve the outcome of severe, necrotizing pneumonia due to community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA). | Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20110301 |
| Safety and pharmacokinetics of higher doses of caspofungin in healthy adult participants. | Journal of clinical pharmacology 20110201 |
| [Prevalence of Candida parapsilosis, C. orthopsilosis and C. metapsilosis in candidemia over a 5-year period at Nantes hospital and in vitro susceptibility to three echinocandins by E-test®]. | Pathologie-biologie 20110201 |
| [Emergence of Candida parapsilosis candidemia at Cochin hospital. Characterization of isolates and search for risk factors]. | Pathologie-biologie 20110201 |
| Caspofungin primes the immune response of the larvae of Galleria mellonella and induces a non-specific antimicrobial response. | Journal of medical microbiology 20110201 |
| Outcomes with micafungin in patients with candidaemia or invasive candidiasis due to Candida glabrata and Candida krusei. | The Journal of antimicrobial chemotherapy 20110201 |
| Catheter-related candidemia caused by Candida haemulonii in a patient in long-term hospital care. | Journal of Korean medical science 20110201 |
| Cell wall integrity is linked to mitochondria and phospholipid homeostasis in Candida albicans through the activity of the post-transcriptional regulator Ccr4-Pop2. | Molecular microbiology 20110201 |
| Lack of pharmacokinetic drug interaction between oral posaconazole and caspofungin or micafungin. | Journal of clinical pharmacology 20110101 |
| A case of Candida krusei peritonitis secondary to duodenal perforation due to Candida duodenitis. | Mycopathologia 20110101 |
| A retrospective analysis of the use of caspofungin in recipients of liver transplant with a modified high index of suspicion for fungal infection. A critical review of mortality, acute cellular rejection, infections, and changes in the liver function tests while on caspofungin. | Clinical transplantation 20110101 |
| In vitro activity of the lipopeptide PAL-Lys-Lys-NH2, alone and in combination with antifungal agents, against clinical isolates of Candida spp. | Peptides 20110101 |
| Changes in cell wall synthesis and ultrastructure during paradoxical growth effect of caspofungin on four different Candida species. | Antimicrobial agents and chemotherapy 20110101 |
| Caspofungin plus posaconazole as salvage therapy of invasive fungal infections in immunocompromised patients. | Mycoses 20110101 |
| Determination of the therapeutic activity of caspofungin compared with the amphotericin B in an animal experimental model of histoplasmosis in hamster (Mesocrisetus auratus). | Revista iberoamericana de micologia 20110101 |
| Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature. | European journal of medical research 20110101 |
| Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis: review of the literature. | European journal of medical research 20110101 |
| Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin:review of the literature. | European journal of medical research 20110101 |
| Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin and its impact on use and costs: review of the literature. | European journal of medical research 20110101 |
| Conservative management of Candida infection of prosthetic aortic graft by means of caspofungin and fluconazole alone. | Texas Heart Institute journal 20110101 |
| Candidemia in children after complex congenital heart defects surgery treated with caspofungin--our own experience and a review of literature. | Medical science monitor : international medical journal of experimental and clinical research 20110101 |
| Coexistence of fatal disseminated invasive aspergillosis and pyoderma gangrenosum: a case report. | Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20110101 |
| [Cardiac invasive aspergillosis in a heart transplant recipient]. | Revista iberoamericana de micologia 20110101 |
| [Development of Candida parapsilosis candidemia during caspofungin therapy]. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20110101 |
| Effect of fluid loading during hypovolaemic shock on caspofungin pharmacokinetic parameters in pig. | Critical care (London, England) 20110101 |
| Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. | PloS one 20110101 |
| Rare form of semi-invasive aspergillosis in immunocompetent patient: case report. | Pneumologia (Bucharest, Romania) 20110101 |
| Successful treatment of Scedosporium apiospermum soft tissue abscess with caspofungin and voriconazole in a severely immunocompromised patient with acute myeloid leukemia. | Transplant infectious disease : an official journal of the Transplantation Society 20101201 |
| Successful treatment of sellar aspergillus abscess. | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20101201 |
| Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspofungin. | Antimicrobial agents and chemotherapy 20101201 |
| Characterization of sensor-specific stress response by transcriptional profiling of wsc1 and mid2 deletion strains and chimeric sensors in Saccharomyces cerevisiae. | Omics : a journal of integrative biology 20101201 |
| [Caspofungin after solid organ transplantation in Germany: observational study on treatment of invasive fungal infections]. | Der Anaesthesist 20101201 |
| In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms. | Journal of Korean medical science 20101201 |
| Evaluating retinal toxicity of intravitreal caspofungin in the mouse eye. | Investigative ophthalmology & visual science 20101101 |
| Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20101101 |
| In vitro and in vivo antifungal susceptibilities of the Mucoralean fungus Cunninghamella. | Antimicrobial agents and chemotherapy 20101101 |
| Recurrent fungal keratitis following penetrating keratoplasty: an unusual source of infection. | Archives of ophthalmology (Chicago, Ill. : 1960) 20101101 |
| In vitro paradoxical growth of Pythium insidiosum in the presence of caspofungin. | Veterinary microbiology 20101026 |
| Effects of caspofungin, Candida albicans and Aspergillus fumigatus on toll-like receptor 9 of GM-CSF-stimulated PMNs. | FEMS immunology and medical microbiology 20101001 |
| Caspofungin versus liposomal amphotericin B: are they really comparable? | The Pediatric infectious disease journal 20101001 |
| Pulmonary aspergillosis in a non-neutropenic critical patient. | The Journal of trauma 20101001 |
| In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin. | Chinese medical journal 20101001 |
| Successful management of postpneumonectomy Aspergillus pleural empyema by combined surgical and anti-fungal treatment with voriconazole and caspofungin. | Mycoses 20100901 |
| Evaluation of the Etest method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins. | Medical mycology 20100901 |
| Invasive respiratory aspergillosis is a treatable disease with early diagnosis and aggressive therapy. | Pediatric hematology and oncology 20100901 |
| Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). | The Journal of antimicrobial chemotherapy 20100901 |
| High rate of breakthrough invasive aspergillosis among patients receiving caspofungin for persistent fever and neutropenia. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20100801 |
| Cunninghamella bertholletiae exhibits increased resistance to human neutrophils with or without antifungal agents as compared to Rhizopus spp. | Medical mycology 20100801 |
| A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients. | The Journal of antimicrobial chemotherapy 20100801 |
| Generation of mutants in Candida albicans with reduced susceptibility to caspofungin: influence on other antifungal products. | Journal of chemotherapy (Florence, Italy) 20100801 |
| Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20100701 |
| Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20100701 |
| Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT. | Bone marrow transplantation 20100701 |
| Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study. | Bone marrow transplantation 20100701 |
| Efficacy of anidulafungin, caspofungin and fluconazole in the early phase of infection in a neutropenic murine invasive candidiasis model. | International journal of antimicrobial agents 20100701 |
| Successful topical application of caspofungin in the treatment of fungal keratitis refractory to voriconazole. | Archives of ophthalmology (Chicago, Ill. : 1960) 20100701 |
| Phaeohyphomycosis due to Alternaria species in transplant recipients. | Transplant infectious disease : an official journal of the Transplantation Society 20100601 |
| Prophylaxis of invasive aspergillosis with voriconazole or caspofungin during building work in patients with acute leukemia. | Haematologica 20100601 |
| Caspofungin for post solid organ transplant invasive fungal disease: results of a retrospective observational study. | Transplant infectious disease : an official journal of the Transplantation Society 20100601 |
| In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii. | International journal of antimicrobial agents 20100601 |
| Liposomal amphotericin B eradicates Candida albicans biofilm in a continuous catheter flow model. | FEMS yeast research 20100601 |
| Proteomic analysis of proteins released from growth-arrested Candida albicans following exposure to caspofungin. | Medical mycology 20100601 |
| Caspofungin-induced severe toxic epidermal necrolysis. | The Annals of pharmacotherapy 20100601 |
| Antifungal therapy with itraconazole impairs the anti-lymphoma effects of rituximab by inhibiting recruitment of CD20 to cell surface lipid rafts. | Cancer research 20100601 |
| Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases. | Mycoses 20100501 |
| Vertebral osteomyelitis due to Aspergillus fumigatus in a patient with chronic granulomatous disease successfully treated with antifungal agents and interferon-gamma. | Medical mycology 20100501 |
| Mycotic pulmonary artery aneurysm due to Aspergillus infection in a patient with leukemia: case report and review of the literature. | Leukemia research 20100501 |
| Wild-type minimum effective concentration distributions and epidemiologic cutoff values for caspofungin and Aspergillus spp. as determined by Clinical and Laboratory Standards Institute broth microdilution methods. | Diagnostic microbiology and infectious disease 20100501 |
| A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia. | The Pediatric infectious disease journal 20100501 |
| Traditional and emerging antifungal therapies. | Proceedings of the American Thoracic Society 20100501 |
| Sclerosing cholangitis and combination antifungal therapy for PNP deficiency patients. | European journal of pediatrics 20100401 |
| Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study. | Haematologica 20100401 |
| In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp. | Antimicrobial agents and chemotherapy 20100401 |
| Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro. | International journal of antimicrobial agents 20100401 |
| Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis. | Clinical therapeutics 20100401 |
| In vivo studies with a Candida tropicalis isolate exhibiting paradoxical growth in vitro in the presence of high concentration of caspofungin. | Journal of microbiology (Seoul, Korea) 20100401 |
| [Specific antifungal treatment in patients with neutropenia and fever: current status of the fungicidal activity of caspofungin]. | Drugs of today (Barcelona, Spain : 1998) 20100401 |
| Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia. | American journal of hematology 20100301 |
| Caspofungin for the treatment of candidaemia in patients with haematological malignancies. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20100301 |
| Urban pigeons (Columba livia) as a potential source of pathogenic yeasts: a focus on antifungal susceptibility of Cryptococcus strains in Northeast Brazil. | Mycopathologia 20100301 |
| Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia. | European journal of haematology 20100301 |
| The Aspergillus fumigatus P-type Golgi apparatus Ca2+/Mn2+ ATPase PmrA is involved in cation homeostasis and cell wall integrity but is not essential for pathogenesis. | Eukaryotic cell 20100301 |
| Successful triple combination therapy of disseminated absidia corymbifera infection in an adolescent with osteosarcoma. | Journal of pediatric hematology/oncology 20100301 |
| The impact of delaying the initiation of appropriate antifungal treatment for Candida bloodstream infection. | Medical mycology 20100301 |
| Mutants of Candida albicans hypersensitive to calcofluor white display susceptibility to antifungal drugs. | Folia microbiologica 20100301 |
| Potential of anti-Candida antibodies in immunoprophylaxis. | Immunotherapy 20100301 |
| In vitro activity of antifungal combinations against Candida albicans biofilms. | The Journal of antimicrobial chemotherapy 20100201 |
| Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatus. | International journal of antimicrobial agents 20100201 |
| Caspofungin-non-susceptible Candida isolates in cancer patients. | The Journal of antimicrobial chemotherapy 20100201 |
| The effects of antifungal agents to conidial and hyphal forms of Aspergillus fumigatus. | Medical mycology 20100201 |
| Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis. | Journal of clinical pharmacy and therapeutics 20100201 |
| Echinocandins: A ray of hope in antifungal drug therapy. | Indian journal of pharmacology 20100201 |
| [Conservative management with new antifungals in a case of Candida prosthetic valve endocarditis]. | Enfermedades infecciosas y microbiologia clinica 20100101 |
| Kodamaea ohmeri fungaemia successfully treated with caspofungin. | International journal of antimicrobial agents 20100101 |
| The echinocandins: three useful choices or three too many? | International journal of antimicrobial agents 20100101 |
| Primary antifungal prophylaxis in acute myeloblastic leukemia and myelodysplastic syndrome--still an open question? | Leukemia & lymphoma 20100101 |
| [Successful treatment of catheter-associated candidemia without removing the central venous line]. | Enfermedades infecciosas y microbiologia clinica 20100101 |
| Caspofungin use in daily clinical practice for treatment of invasive aspergillosis: results of a prospective observational registry. | BMC infectious diseases 20100101 |
| [Successful caspofungin treatment of invasive refractory candidiasis in the extremely low birthweight neonate]. | Acta medica portuguesa 20100101 |
| Lessons from a case of oromandibular mucormycosis treated with surgery and a combination of amphotericin B lipid formulation plus caspofungin. | Acta haematologica 20100101 |
| Safety experience with caspofungin in pediatric patients. | The Pediatric infectious disease journal 20091201 |
| An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients. | The Journal of antimicrobial chemotherapy 20091201 |
| Intraventricular fungus ball: a unique manifestation of refractory intracranial candidiasis in an immunocompetent neonate. | Journal of neurosurgery. Pediatrics 20091201 |
| The effects of caspofungin and voriconazole in an experimental fungal infection of the ear due to Aspergillus. | European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20091101 |
| High caspofungin levels in alveolar cells of a lung transplant patient with suspected pulmonary aspergillosis. | International journal of antimicrobial agents 20091101 |
| Efficacy of caspofungin and itraconazole as secondary antifungal prophylaxis: analysis of data from a multinational case registry. | International journal of antimicrobial agents 20091101 |
| Exposure to caspofungin activates Cap and Hog pathways in Candida albicans. | Medical mycology 20091101 |
| In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms. | International journal of antimicrobial agents 20091001 |
| Intraocular penetration of voriconazole and caspofungin in a patient with fungal endophthalmitis. | The Journal of antimicrobial chemotherapy 20091001 |
| Echinocandins: the newest class of antifungals. | The Annals of pharmacotherapy 20091001 |
| Hyperbaric oxygen therapy and other adjunctive treatments for zygomycosis. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20091001 |
| Immediate cross-hypersensitivity between micafungin and caspofungin: a case report. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20090901 |
| In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii. | International journal of antimicrobial agents 20090901 |
| Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis. | The Journal of antimicrobial chemotherapy 20090901 |
| [Candida albicans endocarditis after pulmonary artery banding]. | Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20090801 |
| Cost-effectiveness analysis of micafungin versus caspofungin for treatment of systemic Candida infections in the UK. | Current medical research and opinion 20090801 |
| Generation of resistance to amphotericin B and caspofungin in Candida spp.: experimental study. | Journal of chemotherapy (Florence, Italy) 20090801 |
| Caspofungin: new indication. Same indications in children as in adults. | Prescrire international 20090801 |
| An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality. | Bone marrow transplantation 20090701 |
| Monotherapy with caspofungin for candidaemia in adult patients with cancer: a retrospective, single institution study. | International journal of antimicrobial agents 20090701 |
| [Successful treatment of neuroaspergillosis in a patient with acute lymphoblastic leukemia: role of surgery, systemic antifungal therapy and intracavitary therapy]. | Mikrobiyoloji bulteni 20090701 |
| A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090615 |
| Frequency of paradoxical effect with caspofungin in Candida albicans. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20090601 |
| In vitro activity of caspofungin and voriconazole against uncommon Candida spp. | International journal of antimicrobial agents 20090601 |
| Economic impact of caspofungin as compared with liposomal amphotericin B for empirical therapy in febrile neutropenia in Australia. | The Journal of antimicrobial chemotherapy 20090601 |
| Infections caused by Candida krusei in five transplant and two surgical patients. | Surgical infections 20090601 |
| Breakthrough rhinocerebral mucormycosis in a liver transplant patient receiving caspofungin. | Transplantation proceedings 20090601 |
| Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients. | Intensive care medicine 20090501 |
| Neonatal liver abscesses due to Candida infection effectively treated with caspofungin. | Acta paediatrica (Oslo, Norway : 1992) 20090501 |
| Successful treatment with caspofungin of refractory Candida krusei candidemia in a very low birth weight preterm infant. | The Pediatric infectious disease journal 20090501 |
| Diagnosis and treatment of aspergillosis in children. | Expert review of anti-infective therapy 20090501 |
| Candida infective endocarditis: report of 15 cases from a prospective multicenter study. | Medicine 20090501 |
| [Argument against the article entitled Caspofungin treatment of a premature infant with mould septicemia]. | Zhonghua er ke za zhi = Chinese journal of pediatrics 20090501 |
| Caspofungin in salvage treatment of severe pneumocystis pneumonia: case report and literature review. | Chinese medical journal 20090420 |
| Alternaria infectoria brain abscess in a child with chronic granulomatous disease. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20090401 |
| Is Candida colonization of central vascular catheters in non-candidemic, non-neutropenic patients an indication for antifungals? | Intensive care medicine 20090401 |
| Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation. | The Journal of antimicrobial chemotherapy 20090401 |
| Successful intensive chemotherapy followed by autologous hematopoietic cell transplantation in a patient with acute myeloid leukemia and hepatosplenic candidiasis: case report and review of literature. | Transplant infectious disease : an official journal of the Transplantation Society 20090401 |
| Compassionate use study of caspofungin in children with proven or suspected invasive mycosis or persistent febrile neutropenia. | Journal of chemotherapy (Florence, Italy) 20090401 |
| Combined antifungal therapy for persistent central venous catheter-related candidemia in extremely low birth weight neonates. | Journal of chemotherapy (Florence, Italy) 20090401 |
| Breakthrough Fusarium spp fungemia during caspofungin therapy in an ABO-incompatible orthotopic liver transplant patient. | Journal of chemotherapy (Florence, Italy) 20090401 |
| [Clinical use of micafungin for the treatment of invasive candidiasis in critical ill patients]. | Revista iberoamericana de micologia 20090331 |
| [Micafungin in invasive candidiasis among oncohematological patients]. | Revista iberoamericana de micologia 20090331 |
| Susceptibility of Candida albicans to common and novel antifungal drugs, and relationship between the mating type locus and resistance, in Lebanese hospital isolates. | Mycoses 20090301 |
| Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20090301 |
| [Invasive pulmonary aspergillosis. Occurrence in a non-neutropenic female patient with abdominal sepsis]. | Der Anaesthesist 20090301 |
| A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients. | Pediatrics 20090301 |
| [Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ]. | Enfermedades infecciosas y microbiologia clinica 20090301 |
| Proteomic and phenotypic profiling of the amphibian pathogen Batrachochytrium dendrobatidis shows that genotype is linked to virulence. | Molecular ecology 20090201 |
| Aspergillus flavus sinusitis in ALL. | American journal of hematology 20090201 |
| Difference in killing activity of caspofungin and paradoxical growth between Candida albicans and C. krusei clinical isolates in different media. | Journal of chemotherapy (Florence, Italy) 20090201 |
| Breakthrough Candida dubliniensis fungemia in an acute myeloid leukemia patient during voriconazole therapy successfully treated with caspofungin. | Journal of chemotherapy (Florence, Italy) 20090201 |
| Oesophageal aspergillosis in a case of acute lymphoblastic leukaemia successfully treated with caspofungin alone due to liposomal amphotericin B induced severe hepatotoxicity. | Mycoses 20090101 |
| Candida endocarditis: role of new antifungal agents. | Mycoses 20090101 |
| Successful treatment of Candida spp. encephalitis occurring under Caspofungin treatment after allogeneic stem cell transplantation. | Annals of hematology 20090101 |
| In vitro synergy of caspofungin with licensed and novel antifungal drugs against clinical isolates of Fusarium spp. | Medical mycology 20090101 |
| The echinocandin caspofungin impairs the innate immune mechanism against Candida parapsilosis. | International journal of antimicrobial agents 20090101 |
| Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation. | Intensive care medicine 20090101 |
| Alternaria keratitis: clinical presentation and resolution with topical fluconazole or intrastromal voriconazole and topical caspofungin. | Cornea 20090101 |
| Aqueous humor concentrations of topically administered caspofungin in rabbits. | Ophthalmic research 20090101 |
| Combined therapy with amphotericin B and caspofungin in an experimental model of disseminated histoplasmosis. | Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 20090101 |
| Caspofungin: in pediatric patients with fungal infections. | Paediatric drugs 20090101 |
| Invasive Aspergillus fumigatus infection after Plasmodium falciparum malaria in an immuno-competent host: case report and review of literature. | Malaria journal 20090101 |
| Successful treatment of Candida albicans septicemia in a preterm infant with severe congenital ichthyosis (Harlequin baby). | Pediatric dermatology 20090101 |
| Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Belgium. | Acta clinica Belgica 20090101 |
| A 6-year-old boy with fever and eosinophilia. | Allergy and asthma proceedings 20090101 |
| [Azole-resistant invasive aspergillosis]. | Nederlands tijdschrift voor geneeskunde 20090101 |
| Anticandidal effects of voriconazole and caspofungin, singly and in combination, against Candida glabrata, extracellularly and intracellularly in granulocyte-macrophage colony stimulating factor (GM-CSF)-activated human monocytes. | The Journal of antimicrobial chemotherapy 20081201 |
| Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms. | The Journal of antimicrobial chemotherapy 20081201 |
| Comparison of killing activity of caspofungin against Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis. | The Journal of antimicrobial chemotherapy 20081201 |
| Membrane-filter bubble-point test. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20081201 |
| Caspofungin for the treatment of pediatric fungal infections. | The Pediatric infectious disease journal 20081201 |
| Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment. | PLoS pathogens 20081201 |
| [Trends in development of new antifungal agents in Japan]. | Nihon rinsho. Japanese journal of clinical medicine 20081201 |
| [In vitro activity of anidulafungin. Comparison with the activity of other echinocandins]. | Enfermedades infecciosas y microbiologia clinica 20081201 |
| [Pharmacokinetics and pharmacodynamics: interactions and adverse effects. Comparison with other echinocandins]. | Enfermedades infecciosas y microbiologia clinica 20081201 |
| Invasive aspergillosis in paediatric oncology patients. | The Medical journal of Malaysia 20081201 |
| A clinical cohort trial of antifungal combination therapy: efficacy and toxicity in haematological cancer patients. | Annals of hematology 20081101 |
| Evaluation of aminocandin and caspofungin against Candida glabrata including isolates with reduced caspofungin susceptibility. | The Journal of antimicrobial chemotherapy 20081101 |
| In vitro susceptibility of Pythium insidiosum and a Lagenidium sp to itraconazole, posaconazole, voriconazole, terbinafine, caspofungin, and mefenoxam. | American journal of veterinary research 20081101 |
| Acute refractory hyperkalaemia and fatal cardiac arrest related to administration of liposomal amphotericin B. | The Netherlands journal of medicine 20081101 |
| Caspofungin. | Indian pediatrics 20081101 |
| Efalizumab treatment associated with Candida colitis. | Journal of the American Academy of Dermatology 20081101 |
| Double-blind active-control trials: beware the comparator you keep. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20081015 |
| Subculture on potato dextrose agar as a complement to the broth microdilution assay for Malassezia pachydermatis. | Journal of microbiological methods 20081001 |
| Functional analysis of Candida albicans GPI-anchored proteins: roles in cell wall integrity and caspofungin sensitivity. | Fungal genetics and biology : FG & B 20081001 |
| [Tolerance of caspofungin in intensive care unit: a prospective study]. | Annales francaises d'anesthesie et de reanimation 20081001 |
| Chronic necrotizing and allergic bronchopulmonary aspergillosis in an asthmatic patient--a therapeutic challenge. | The clinical respiratory journal 20081001 |
| Disseminated aspergillosis in an adolescent with acute lymphoblastic leukemia. | Pediatric blood & cancer 20080901 |
| Antifungal activity against Candida albicans of nikkomycin Z in combination with caspofungin, voriconazole or amphotericin B. | The Journal of antimicrobial chemotherapy 20080901 |
| Significant differences in drug susceptibility among species in the Candida parapsilosis group. | Diagnostic microbiology and infectious disease 20080901 |
| Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study. | Journal of clinical microbiology 20080901 |
| Treatment of invasive candidal infections: systematic review and meta-analysis. | Mayo Clinic proceedings 20080901 |
| Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital. | Medical mycology 20080901 |
| Efficacy and safety of caspofungin therapy in elderly patients with proven or suspected invasive fungal infections. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20080801 |
| In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates. | Antimicrobial agents and chemotherapy 20080801 |
| Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080801 |
| Effective management of pulmonary aspergillosis invading the thoracic spine in a child with high risk ALL requiring allogeneic bone marrow transplantation. | Medical mycology 20080801 |
| Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposure. | The Journal of infectious diseases 20080715 |
| Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae. | The Journal of infectious diseases 20080715 |
| Time-kill studies investigating the killing activity of caspofungin against Candida dubliniensis: comparing RPMI-1640 and antibiotic medium 3. | The Journal of antimicrobial chemotherapy 20080701 |
| In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth. | The Journal of antimicrobial chemotherapy 20080701 |
| Treatment of a critically ill child with disseminated Candida glabrata with a recombinant human antibody specific for fungal heat shock protein 90 and liposomal amphotericin B, caspofungin, and voriconazole. | Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 20080701 |
| Caspofungin-resistant Aspergillus flavus after heart transplantation and mechanical circulatory support: a case report. | Transplant infectious disease : an official journal of the Transplantation Society 20080601 |
| Therapeutic and prophylactic efficacy of aminocandin (IP960) against disseminated candidiasis in mice. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20080601 |
| [Treatment of fungal septicemia in a premature infant with caspofungin]. | Zhonghua er ke za zhi = Chinese journal of pediatrics 20080601 |
| Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive Aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080515 |
| Efungumab and caspofungin: pre-clinical data supporting synergy. | The Journal of antimicrobial chemotherapy 20080501 |
| Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis. | The Journal of antimicrobial chemotherapy 20080501 |
| Successful treatment of disseminated Geotrichum capitatum infection with a combination of caspofungin and voriconazole in an immunocompromised patient. | Mycoses 20080501 |
| Characterization of caspofungin susceptibilities by broth and agar in Candida albicans clinical isolates with characterized mechanisms of azole resistance. | Medical mycology 20080501 |
| New options for treatment of candidaemia in critically ill patients. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20080501 |
| Comparison of the efficacy of combination and monotherapy with caspofungin and liposomal amphotericin B against invasive candidiasis. | Saudi medical journal 20080501 |
| Defining targets for investigating the pharmacogenomics of adverse drug reactions to antifungal agents. | Pharmacogenomics 20080501 |
| Economic evaluation of caspofungin vs liposomal amphotericin B for empirical therapy of suspected systemic fungal infection in the German hospital setting. | Annals of hematology 20080401 |
| Fluvastatin potentiates the activity of caspofungin against Aspergillus fumigatus in vitro. | Diagnostic microbiology and infectious disease 20080401 |
| Multilaboratory testing of antifungal combinations against a quality control isolate of Candida krusei. | Antimicrobial agents and chemotherapy 20080401 |
| Successful treatment of prosthetic knee Candida glabrata infection with caspofungin combined with flucytosine. | International journal of antimicrobial agents 20080401 |
| Breakthrough C. parapsilosis and C. guilliermondii blood stream infections in allogeneic hematopoietic stem cell transplant recipients receiving long-term caspofungin therapy. | Haematologica 20080401 |
| Acute monoblastic leukemia with t(10;11)(p12;q23) presenting with pulmonary involvement: a case report and literature review. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20080401 |
| Comparison of microdilution method and E-test procedure in susceptibility testing of caspofungin against Candida non-albicans species. | The new microbiologica 20080401 |
| Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin. | Leukemia 20080301 |
| Visual compatibility of caspofungin acetate with commonly used drugs during simulated Y-site delivery. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080301 |
| [Cutaneous, pulmonary and bone aspergillosis in a patient presumed immunocompetent presenting subacute cutaneous lupus erythematosus]. | Annales de dermatologie et de venereologie 20080301 |
| Points of concern related to the micafungin versus caspofungin trial. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080215 |
| Candida krusei--a serious complication in patients with hematological malignancies: successful treatment with caspofungin. | Transplant infectious disease : an official journal of the Transplantation Society 20080201 |
| Successfully treated Candida krusei infection of the lumbar spine with combined caspofungin/posaconazole therapy. | Medical mycology 20080201 |
| Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin. | Infection 20080201 |
| Combined voriconazole plus caspofungin therapy for the treatment of probable Geotrichum pneumonia in a leukemia patient. | Infection 20080201 |
| Posaconazole activity against Candida glabrata after exposure to caspofungin or amphotericin B. | Antimicrobial agents and chemotherapy 20080201 |
| Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C. dubliniensis. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20080201 |
| Increasing incidence of Candida parapsilosis candidemia with caspofungin usage. | The Journal of infection 20080201 |
| Candida dubliniensis meningitis as delayed sequela of treated C. dubliniensis fungemia. | Emerging infectious diseases 20080201 |
| [Antifungal activity of posaconazole and caspofungin in yeast causing invasive fungal infection (2002-2003). E-test system evaluation]. | Enfermedades infecciosas y microbiologia clinica 20080201 |
| Invasive pulmonary aspergillosis after liver transplantation: rapid and complete response to combined and sequential antifungal therapy. | Surgical infections 20080201 |
| Multifocal Scedosporium apiospermum spondylitis in a cystic fibrosis patient. | Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 20080101 |
| Emergence of Candida tropicalis resistant to caspofungin. | The Journal of antimicrobial chemotherapy 20080101 |
| Activity of caspofungin and voriconazole against clinical isolates of Candida and other medically important yeasts by the CLSI M-44A disk diffusion method with Neo-Sensitabs tablets. | Chemotherapy 20080101 |
| Caspofungin as first-line therapy for the treatment of invasive aspergillosis after thoracic organ transplantation. | The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20080101 |
| Successful treatment of invasive Aspergillus sinusitis with caspofungin and voriconazole. | Ear, nose, & throat journal 20080101 |
| Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofungin. | Critical care (London, England) 20080101 |
| Developments in the epidemiolgy of invasive fungal infections - implications for the empiric and targeted antifungal therapy. | Mycoses 20080101 |
| Comedication of caspofungin acetate and cyclosporine A after allogeneic haematopoietic stem cell transplantation leads to negligible hepatotoxicity. | Mycoses 20080101 |
| Efficacy of caspofungin in invasive candidiasis and candidemia--de-escalation strategy. | Mycoses 20080101 |
| Caspofungin for treatment of invasive aspergillus infections. | Mycoses 20080101 |
| Experiences with the use of caspofungin in paediatric patients. | Mycoses 20080101 |
| Pneumocystis jiroveci pneumonia in a patient with Wegener's granulomatosis treated efficiently with caspofungin. | Mycoses 20080101 |
| Economic evaluation of caspofungin versus liposomal amphotericin B for empiric antifungal treatment in patients with neutropenic fever in Italy. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20080101 |
| Hospital-acquired invasive pulmonary aspergillosis in patients with hepatic failure. | BMC gastroenterology 20080101 |
| Antifungal susceptibility of 95 yeast strains isolated from oral mycoses in HIV-negative and HIV-positive patients. | Bacteriologia, virusologia, parazitologia, epidemiologia (Bucharest, Romania : 1990) 20080101 |
| Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat trial). | Cancer 20071215 |
| Efficacy of caspofungin and posaconazole in a murine model of disseminated Exophiala infection. | Medical mycology 20071201 |
| Caspofungin reduces the incidence of fungal contamination in cell culture. | Mycopathologia 20071201 |
| Therapeutic efficacy of caspofungin alone and in combination with amphotericin B deoxycholate for coccidioidomycosis in a mouse model. | The Journal of antimicrobial chemotherapy 20071201 |
| Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin. | International journal of antimicrobial agents 20071201 |
| Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients. | Pharmacotherapy 20071201 |
| Efficacy and safety of caspofungin in solid organ transplant recipients. | Transplantation proceedings 20071201 |
| [The fungicidal activity and paradoxical effect of caspofungin against yeast. Influence of culture medium and incubation time]. | Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20071201 |
| Survival in the presence of antifungals: genome-wide expression profiling of Aspergillus niger in response to sublethal concentrations of caspofungin and fenpropimorph. | The Journal of biological chemistry 20071109 |
| Lethal double infection with Acremonium strictum and Aspergillus fumigatus during induction chemotherapy in a child with ALL. | Pediatric blood & cancer 20071101 |
| Caspofungin in vitro and in vivo activity against Brazilian Pythium insidiosum strains isolated from animals. | The Journal of antimicrobial chemotherapy 20071101 |
| Requirement for Candida albicans Sun41 in biofilm formation and virulence. | Eukaryotic cell 20071101 |
| Disseminated invasive aspergillosis with cerebral involvement successfully treated with caspofungin and voriconazole. | Infection 20071001 |
| Candidemia-induced acute interstitial nephritis. | Nephrology (Carlton, Vic.) 20071001 |
| Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20071001 |
| Efficacy of caspofungin addition to trimethoprim-sulfamethoxazole treatment for severe pneumocystis pneumonia in solid organ transplant recipients. | Transplantation 20070927 |
| Successful treatment of refractory chronic disseminated candidiasis after prolonged administration of caspofungin in a child with acute myeloid leukemia. | Pediatric blood & cancer 20070901 |
| Successful treatment of invasive candidiasis with caspofungin in a child with acute lymphoblastic leukemia. | Pediatric blood & cancer 20070901 |
| Synergistic effect of posaconazole and caspofungin against clinical zygomycetes. | Antimicrobial agents and chemotherapy 20070901 |
| Efficacy and safety of caspofungin for the empiric management of fever in neutropenic children. | The Pediatric infectious disease journal 20070901 |
| Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trial. | Journal of critical care 20070901 |
| In vitro activities of voriconazole as a triazole derivative and caspofungin as an echinocandin were compared with those of some antifungal agents against Candida species isolated from clinical specimens. | Japanese journal of infectious diseases 20070901 |
| Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation. | European journal of medical research 20070816 |
| Caspofungin for the treatment of less common forms of invasive candidiasis. | The Journal of antimicrobial chemotherapy 20070801 |
| Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection. | Bone marrow transplantation 20070801 |
| Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach. | The Journal of antimicrobial chemotherapy 20070801 |
| Single- and multiple-dose administration of caspofungin in patients with hepatic insufficiency: implications for safety and dosing recommendations. | Journal of clinical pharmacology 20070801 |
| Assessing the antifungal activity, pharmacokinetics, and tissue distribution of amphotericin B following the administration of Abelcet and AmBisome in combination with caspofungin to rats infected with Aspergillus fumigatus. | Journal of pharmaceutical sciences 20070701 |
| In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. | Antimicrobial agents and chemotherapy 20070701 |
| Factors influencing caspofungin plasma concentrations in patients of a surgical intensive care unit. | The Journal of antimicrobial chemotherapy 20070701 |
| Efficacy of topical caspofungin in experimental fusarium keratitis. | Cornea 20070701 |
| Basidiomycetous fungal Inonotus tropicalis sacral osteomyelitis in X-linked chronic granulomatous disease. | The Pediatric infectious disease journal 20070701 |
| A comparative evaluation of properties and clinical efficacy of the echinocandins. | Expert opinion on pharmacotherapy 20070701 |
| Ocular penetration of caspofungin in a rabbit uveitis model. | Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20070601 |
| A retrospective nationwide case study on the use of a new antifungal agent: patients treated with caspofungin during 2001-2004 in Finland. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20070601 |
| A cost-effectiveness analysis of caspofungin vs. liposomal amphotericin B for treatment of suspected fungal infections in the UK. | European journal of haematology 20070601 |
| Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin. | Journal of clinical microbiology 20070601 |
| Successful management of Aspergillus liver abscess in a patient with necrotizing fasciitis. | Digestive diseases and sciences 20070601 |
| Acquired resistance to echinocandins in Candida albicans: case report and review. | The Journal of antimicrobial chemotherapy 20070601 |
| The use of caspofungin in HIV-infected individuals. | Expert opinion on investigational drugs 20070601 |
| A colorimetric and spectrophotometric method for in vitro susceptibility testing of Aspergillus species against caspofungin. | Medical mycology 20070601 |
| Diagnostic and therapeutic challenge of Aspergillus flavus scleritis. | Cornea 20070601 |
| Secular trends in severe renal failure associated with the use of new antimicrobial agents in critically ill surgical patients. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20070601 |
| Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis. | Archives of ophthalmology (Chicago, Ill. : 1960) 20070601 |
| In vitro activity of fluconazole, voriconazole and caspofungin against clinical yeast isolates. | Journal of chemotherapy (Florence, Italy) 20070601 |
| Persistence of Candida albicans candidemia in non-neutropenic surgical patients: management of a representative patient in the absence of second-line treatment guidelines. | Journal of chemotherapy (Florence, Italy) 20070601 |
| Nebulized liposomal amphotericin B and combined systemic antifungal therapy for the treatment of severe pulmonary aspergillosis after allogeneic hematopoietic stem cell transplant for a fatal mitochondrial disorder. | Journal of chemotherapy (Florence, Italy) 20070601 |
| [Native valve Aspergillus fumigatus endocarditis with blood culture positive and negative for galactomannan antigen. Case report and literature review]. | Revista iberoamericana de micologia 20070601 |
| Caspofungin in kidney transplant recipients with refractory invasive candidiasis. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070501 |
| Liquid chromatography-mass spectrometry method for quantification of caspofungin in clinical plasma samples. | Journal of mass spectrometry : JMS 20070401 |
| The pharmacology and clinical use of caspofungin. | Expert opinion on drug metabolism & toxicology 20070401 |
| [Biofilm production and antifungal susceptibility patterns of Candida species isolated from hospitalized patients]. | Mikrobiyoloji bulteni 20070401 |
| [Comparison of minimum inhibitory and minimum effective concentration values for the detection of in vitro susceptibilities of Aspergillus species against caspofungin]. | Mikrobiyoloji bulteni 20070401 |
| [Intracranial aspergillosis in an immunocompetent patient]. | Mikrobiyoloji bulteni 20070401 |
| Synthesis of the antifungal beta-1,3-glucan synthase inhibitor CANCIDAS (caspofungin acetate) from pneumocandin B0. | The Journal of organic chemistry 20070330 |
| Pharmacoeconomic analysis of caspofungin versus liposomal amphotericin B as empirical antifungal therapy for neutropenic fever. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070315 |
| Autologous transplantation of CD133 selected hematopoietic progenitor cells for treatment of relapsed acute lymphoblastic leukemia. | Pediatric blood & cancer 20070301 |
| In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates. | Diagnostic microbiology and infectious disease 20070301 |
| Caspofungin in the treatment of symptomatic candiduria. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070301 |
| When a paradoxical increase in serum galactomannan antigen during caspofungin therapy is not paradoxical after all. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070301 |
| The echinocandins. | Pharmacotherapy 20070301 |
| Induction of a high affinity fibronectin receptor in Candida albicans by caspofungin: requirements for beta (1,6) glucans and the developmental regulator Hbr1p. | Medical mycology 20070301 |
| Caspofungin for the treatment of fungal infections: a systematic review of randomized controlled trials. | International journal of antimicrobial agents 20070201 |
| High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation. | Bone marrow transplantation 20070201 |
| Caspofungin for the treatment of azole resistant candidemia in a premature infant. | Journal of perinatology : official journal of the California Perinatal Association 20070201 |
| Candida inferior vena cava filter infection and septic thrombophlebitis. | The British journal of radiology 20070201 |
| Caspofungin-resistant oral and esophageal candidiasis in a patient with AIDS. | AIDS (London, England) 20070102 |
| Effect of caspofungin on trophozoites and cysts of three species of Acanthamoeba. | The Journal of antimicrobial chemotherapy 20070101 |
| Invasive esophageal aspergillosis associated with acute myelogenous leukemia: successful therapy with combination caspofungin and liposomal amphotericin B. | Pediatric hematology and oncology 20070101 |
| Cerebral aspergillosis diagnosed by detection of Aspergillus flavus-specific DNA, galactomannan and (1-->3)-beta-D-glucan in clinical specimens. | Journal of medical microbiology 20070101 |
| Susceptibility of environmental versus clinical strains of pathogenic Aspergillus. | International journal of antimicrobial agents 20070101 |
| Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Spain. | Clinical drug investigation 20070101 |
| The effects of caspofungin and voriconazole in experimental Candida endophthalmitis. | Current eye research 20070101 |
| Caspofungin as salvage monotherapy for invasive aspergillosis in patients with haematological malignancies or following allogeneic stem cell transplantation: efficacy and concomitant cyclosporin A. | Mycoses 20070101 |
| Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients. | BMC infectious diseases 20070101 |
| Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report. | BMC infectious diseases 20070101 |
| Treatment of two postoperative endophthalmitis cases due to Aspergillus flavus and Scopulariopsis spp. with local and systemic antifungal therapy. | BMC infectious diseases 20070101 |
| Voriconazole in the treatment of invasive aspergillosis in kidney transplant recipients. | Transplantation proceedings 20070101 |
| Adjuvant endobronchial amphotericin B for refractory invasive pulmonary aspergillosis: evidence is scarce but promise does exist. | Respiration; international review of thoracic diseases 20070101 |
| Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis. | Cancer 20061215 |
| [Successful treatment with caspofungin of an invasive candidosis resistant to liposomal amphotericin B in a neutropenic patient]. | Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20061201 |
| Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species. | The Journal of antimicrobial chemotherapy 20061201 |
| Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus. | The Journal of antimicrobial chemotherapy 20061201 |
| Efficacy and safety of caspofungin therapy in children with invasive fungal infections. | The Pediatric infectious disease journal 20061201 |
| Safety profile of concomitant use of caspofungin and cyclosporine or tacrolimus in liver transplant patients. | Infection 20061201 |
| Development of candidemia on caspofungin therapy: a case report. | Infection 20061201 |
| Efficacies of caspofungin and a combination of caspofungin and meropenem in the treatment of murine disseminated candidiasis. | APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 20061201 |
| Caspofungin: a major breakthrough in treatment of systemic fungal infections. | The Journal of the Association of Physicians of India 20061201 |
| Antifungal alternatives for invasive candidiasis refractory to caspofungin in liver transplant recipients: A report of two cases. | Transplantation 20061127 |
| Unexplained increase in Paecilomyces variotii blood culture isolates in the UK. | Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 20061116 |
| Development of a high-performance liquid chromatography method for the determination of caspofungin with amperometric detection and its application to in vitro microdialysis experiments. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20061107 |
| Comparison of antifungal treatments for murine fusariosis. | The Journal of antimicrobial chemotherapy 20061101 |
| Multi-azole resistance in Aspergillus fumigatus. | International journal of antimicrobial agents 20061101 |
| Caspofungin for invasive candidiasis at a tertiary care medical center. | The American journal of medicine 20061101 |
| Successful treatment of Candida krusei fungemia with amphotericin B and caspofungin. | Medical mycology 20061101 |
| Comparison of susceptibility and transcription profile of the new antifungal hassallidin A with caspofungin. | Biochemical and biophysical research communications 20061020 |
| Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20061015 |
| New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20061015 |
| Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment? | European journal of haematology 20061001 |
| Echinocandins in the management of invasive fungal infections, Part 2. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20061001 |
| An open study of the comparative efficacy and safety of caspofungin and liposomal amphotericin B in treating invasive fungal infections or febrile neutropenia in patients with haematological malignancy. | Journal of medical microbiology 20061001 |
| Clinical efficacy and tolerability of caspofungin in a renal transplant patient with Aspergillus flavus lung infection: case report. | Journal of chemotherapy (Florence, Italy) 20061001 |
| Epidemiology and outcome of Rhodotorula fungemia in a tertiary care hospital. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060915 |
| Echinocandins for candidemia in adults without neutropenia. | The New England journal of medicine 20060914 |
| Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model. | The Journal of infectious diseases 20060901 |
| Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young woman. | International journal of antimicrobial agents 20060901 |
| Successful initial treatment with caspofungin alone for hepatosplenic candidiasis in a patient with acute myeloblastic leukemia. | Saudi medical journal 20060901 |
| Trichosporon asahii. Blood-stream infection in a non-cancer patient receiving combination antifungal therapy. | The Ulster medical journal 20060901 |
| Efficacy of amphotericin B or amphotericin B-intralipid in combination with caspofungin against experimental aspergillosis. | The Journal of infection 20060801 |
| Unclear fever 7 weeks after renal transplantation in a 56-year-old patient. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20060801 |
| Caspofungin activity against clinical isolates of azole cross-resistant Candida glabrata overexpressing efflux pump genes. | The Journal of antimicrobial chemotherapy 20060801 |
| Paradoxical increase in circulating Aspergillus antigen during treatment with caspofungin in a patient with pulmonary aspergillosis. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060801 |
| Specific antibody to Cryptococcus neoformans glucurunoxylomannan antagonizes antifungal drug action against cryptococcal biofilms in vitro. | The Journal of infectious diseases 20060715 |
| Candida albicans endocarditis treatment with caspofungin in an HIV-infected patient--case report and review of literature. | The Journal of infection 20060701 |
| Interaction between posaconazole and caspofungin in concomitant treatment of mice with systemic Aspergillus infection. | Antimicrobial agents and chemotherapy 20060701 |
| Disruption of the Aspergillus fumigatus ECM33 homologue results in rapid conidial germination, antifungal resistance and hypervirulence. | Microbiology (Reading, England) 20060701 |
| FsFKS1, the 1,3-beta-glucan synthase from the caspofungin-resistant fungus Fusarium solani. | Eukaryotic cell 20060701 |
| [The treatment of pneumocystis Carinii pneumonia with caspofungin in elderly patients: a case report and literature review]. | Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 20060701 |
| Caspofungin: an advanced treatment approach for suspected or confirmed invasive aspergillosis. | International journal of antimicrobial agents 20060601 |
| Antifungal combination treatment: a future perspective. | International journal of antimicrobial agents 20060601 |
| Progressive esophagitis caused by Candida albicans with reduced susceptibility to caspofungin. | Pharmacotherapy 20060601 |
| In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis. | Antimicrobial agents and chemotherapy 20060601 |
| A case of pulmonary aspergillosis with lack of response to caspofungin. | Revista iberoamericana de micologia 20060601 |
| Modern antifungal therapy for neutropenic fever. | Current hematologic malignancy reports 20060601 |
| Possible hepatosplenic candidiasis treated with liposomal amphotericin B and caspofungin combination. | The Journal of infection 20060501 |
| Emerging echinocandins for treatment of invasive fungal infections. | Expert opinion on emerging drugs 20060501 |
| Successful caspofungin treatment of multidrug resistant Candida parapsilosis septicaemia in an extremely low birth weight neonate. | Mycoses 20060501 |
| Caspofungin in the treatment of azole-refractory esophageal candidiasis in kidney transplant recipients. | Transplantation proceedings 20060501 |
| Successful treatment of Candida tropicalis arthritis, osteomyelitis and costochondritis with caspofungin and fluconazole in a recipient of bone marrow transplantation. | Acta paediatrica (Oslo, Norway : 1992) 20060501 |
| Caspofungin: antifungal activity in vitro, pharmacokinetics, and effects on fungal load and animal survival in neutropenic rats with invasive pulmonary aspergillosis. | The Journal of antimicrobial chemotherapy 20060401 |
| Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures. | Diagnostic microbiology and infectious disease 20060401 |
| Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060401 |
| Echinocandin antifungals: review and update. | Expert review of anti-infective therapy 20060401 |
| Successful treatment of liposomal amphotericin B refractory Candida glabrata fungaemia in a patient undergoing a stem cell transplantation. | The Netherlands journal of medicine 20060401 |
| Trichosporon asahii fungemia in a patient with non-hematological malignancy. | Japanese journal of infectious diseases 20060401 |
| A drug-sensitive genetic network masks fungi from the immune system. | PLoS pathogens 20060401 |
| Treatment with caspofungin in immunocompromised paediatric patients: a multicentre survey. | The Journal of antimicrobial chemotherapy 20060301 |
| Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. | Antimicrobial agents and chemotherapy 20060301 |
| [Systemic antifungals. Pharmacodynamics and pharmacokinetics]. | Revista iberoamericana de micologia 20060301 |
| Caspofungin for refractory candidemia in neonates. | The Pediatric infectious disease journal 20060301 |
| Control of the C. albicans cell wall damage response by transcriptional regulator Cas5. | PLoS pathogens 20060301 |
| Impact of alternate definitions of fever resolution on the composite endpoint in clinical trials of empirical antifungal therapy for neutropenic patients with persistent fever: analysis of results from the Caspofungin Empirical Therapy Study. | Transplant infectious disease : an official journal of the Transplantation Society 20060301 |
| Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. | Transplantation 20060215 |
| Caspofungin in the treatment of invasive fungal infections. | Intensive & critical care nursing 20060201 |
| Fungal infections in solid organ transplantation. | Expert opinion on pharmacotherapy 20060201 |
| Fungal infections in bone marrow transplant recipients. | Expert opinion on pharmacotherapy 20060201 |
| Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients. | Cancer 20060115 |
| [Caspofungin: mode of action and therapeutic applications]. | La Revue de medecine interne 20060101 |
| Treatment of peritoneal dialysis related fungal peritonitis with caspofungin plus amphotericin B combination therapy. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20060101 |
| Caspofungin treatment in severely ill, immunocompromised patients: a case-documentation study of 118 patients. | The Journal of antimicrobial chemotherapy 20060101 |
| Successful treatment of fungus balls due to fluconazole-resistant Candida sake obstructing ureter stents in a renal transplant patient. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20060101 |
| Caspofungin treatment of Pneumocystis pneumonia during conditioning for bone marrow transplantation. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20060101 |
| Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections. | The Journal of infection 20060101 |
| In vitro activities of caspofungin, amphotericin B and azoles against Coccidioides posadasii strains from Northeast, Brazil. | Mycopathologia 20060101 |
| Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole. | BMC infectious diseases 20060101 |
| Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole. | BMC infectious diseases 20060101 |
| Combined mucormycosis and Aspergillosis of the rhinocerebral region. | In vivo (Athens, Greece) 20060101 |
| Combined trimethoprim and caspofungin treatment for severe Pneumocystis jiroveci pneumonia in a five year old boy with acute lymphoblastic leukemia. | Klinische Padiatrie 20060101 |
| Caspofungin treatment in two infants with persistent fungaemia due to Candida lipolytica. | Scandinavian journal of infectious diseases 20060101 |
| Successful treatment of Candida parapsilosis (fluconazole-resistant) osteomyelitis with caspofungin in a HIV patient. | Scandinavian journal of infectious diseases 20060101 |
| Limitations of caspofungin in the treatment of obstructive pyonephrosis due to Candida glabrata infection. | BMC infectious diseases 20060101 |
| Disseminated invasive aspergillosis in a patient with acute leukaemia. | Acta bio-medica : Atenei Parmensis 20060101 |
| Successful combined antifungal salvage therapy with liposomal amphothericin B and caspofungin for invasive Aspergillus flavus infection in a child following allogeneic bone marrow transplantation. | Acta bio-medica : Atenei Parmensis 20060101 |
| [Efficacies and clinical roles of new antifungal agents]. | Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology 20060101 |
| [Antifungals cellular targets and mechanisms of resistance]. | Therapie 20060101 |
| Native valve Aspergillus endocarditis in two patients with aplastic anaemia. | Scandinavian journal of infectious diseases 20060101 |
| Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole. | Scandinavian journal of infectious diseases 20060101 |
| A case of candida albicans mediastinitis after heart transplantation successfully treated with caspofungin. | Annals of transplantation 20060101 |
| The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications. | Pharmacology 20060101 |
| Successful treatment of azole-resistant chronic mucocutaneous candidosis with caspofungin. | Acta dermato-venereologica 20060101 |
| [Isolated renal mucormicosis]. | Gaceta medica de Mexico 20060101 |
| An update on the use of antifungal agents. | Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 20060101 |
| In vitro activity of caspofungin against planktonic and sessile Candida sp. cells. | Polish journal of microbiology 20060101 |
| Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis. | Annals of internal medicine 20051220 |
| Safety and potential of drug interactions of caspofungin and voriconazole in multimorbid patients. | Pharmacology 20051201 |
| Experience with caspofungin in the treatment of persistent fungemia in neonates. | Journal of perinatology : official journal of the California Perinatal Association 20051201 |
| Septic Candida krusei thrombophlebitis of inferior vena cava with persistent fungemia successfully treated by new antifungal agents. | Medical mycology 20051201 |
| [Antifungal inhibitors of glucan synthesis]. | Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20051201 |
| Successful treatment of rhinocerebral zygomycosis with a combination of caspofungin and liposomal amphotericin B. | Haematologica 20051201 |
| Comparison of galactomannan detection, PCR-enzyme-linked immunosorbent assay, and real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model and effect of caspofungin acetate. | Clinical and diagnostic laboratory immunology 20051101 |
| Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20051101 |
| Mediastinal mass due to Aspergillus fumigatus after lung transplantation: a case report. | The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20051101 |
| Suitability of caspofungin for aerosol delivery: physicochemical profiling and nebulizer choice. | Chest 20051101 |
| Aspergillus flavus scleritis: successful treatment with voriconazole and caspofungin. | Medical mycology 20051101 |
| Absence of clinically relevant effect of caspofungin on cyclosporin pharmacokinetics. | Swiss medical weekly 20051029 |
| Liquid chromatography-mass spectrometry using the hydrogen/deuterium exchange reaction as a tool for impurity identification in pharmaceutical process development. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20051025 |
| Caspofungin is less nephrotoxic than amphotericin B in vitro and predominantly damages distal renal tubular cells. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20051001 |
| Cell wall integrity is dependent on the PKC1 signal transduction pathway in Cryptococcus neoformans. | Molecular microbiology 20051001 |
| Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. | British journal of haematology 20051001 |
| Caspofungin: an overview. | Expert review of anti-infective therapy 20051001 |
| Drug-drug interactions of antifungal agents and implications for patient care. | Expert opinion on pharmacotherapy 20051001 |
| Advances in antifungal therapy. | The Pediatric infectious disease journal 20051001 |
| Cryptococcal fungemia in a neutropenic patient with AIDS while receiving caspofungin. | The Journal of infection 20051001 |
| Voriconazole for candidosis: an important addition? | Lancet (London, England) 20051001 |
| Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis. | Infection 20051001 |
| Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi. | Science (New York, N.Y.) 20050930 |
| Experimental systemic murine aspergillosis: treatment with polyene and caspofungin combination and G-CSF. | The Journal of antimicrobial chemotherapy 20050901 |
| Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms. | The Journal of antimicrobial chemotherapy 20050901 |
| Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies. | European journal of haematology 20050901 |
| Caspofungin treatment failure in a patient with invasive candidiasis and concomitant rifampicin treatment. | International journal of antimicrobial agents 20050901 |
| Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin. | American journal of ophthalmology 20050901 |
| Combination antifungal therapy for invasive aspergillosis: utilizing new targeting strategies. | Current drug targets. Infectious disorders 20050901 |
| Safety of caspofungin for treating invasive nasal sinus aspergillosis in a kidney transplant recipient. | Transplantation proceedings 20050901 |
| [Economic evaluation of the treatment of systemic fungal infections in immunocompromised patients: the role of itraconazole]. | Recenti progressi in medicina 20050901 |
| Emergence of disseminated candidiasis caused by Candida krusei during treatment with caspofungin: case report and review of literature. | Medical mycology 20050901 |
| Oral epithelial cell antifungal activity: approaches to evaluate a broad range of clinical conditions. | Medical mycology 20050901 |
| Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050801 |
| Neonatal cutaneous fungal infections. | Current opinion in pediatrics 20050801 |
| In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata. | Antimicrobial agents and chemotherapy 20050801 |
| Antifungal treatment in pediatric patients. | Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 20050801 |
| Echinocandins: role in antifungal therapy, 2005. | Expert opinion on pharmacotherapy 20050801 |
| Yapsins are a family of aspartyl proteases required for cell wall integrity in Saccharomyces cerevisiae. | Eukaryotic cell 20050801 |
| Efficacy of Abelcet and caspofungin, alone or in combination, against CNS aspergillosis in a murine model. | The Journal of antimicrobial chemotherapy 20050701 |
| Evaluation of serum sandwich enzyme-linked immunosorbent assay for circulating galactomannan during caspofungin therapy: results from the caspofungin invasive aspergillosis study. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050701 |
| Cryptococcus neoformans resistance to echinocandins: (1,3)beta-glucan synthase activity is sensitive to echinocandins. | Antimicrobial agents and chemotherapy 20050701 |
| Pharmacological properties and clinical efficacy of a recently licensed systemic antifungal, caspofungin. | Mycoses 20050701 |
| In vitro susceptibility of 15 strains of zygomycetes to nine antifungal agents as determined by the NCCLS M38-A microdilution method. | Mycoses 20050701 |
| Successful antifungal combination therapy with voriconazole and caspofungin. | Pediatric blood & cancer 20050615 |
| [Update on therapy of invasive mycoses in hematology and oncology]. | Deutsche medizinische Wochenschrift (1946) 20050603 |
| Candida krusei fungemia in an unrelated allogeneic hematopoietic stem cell transplant patient successfully treated with Caspofungin. | Bone marrow transplantation 20050601 |
| Effect of media composition and in vitro activity of posaconazole, caspofungin and voriconazole against zygomycetes. | The Journal of antimicrobial chemotherapy 20050601 |
| Invasive candidiasis in cancer patients: observations from a randomized clinical trial. | The Journal of infection 20050601 |
| Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. | Antimicrobial agents and chemotherapy 20050601 |
| Antifungal agents in children. | Pediatric clinics of North America 20050601 |
| Voriconazole: review of a broad spectrum triazole antifungal agent. | Expert opinion on pharmacotherapy 20050601 |
| [Comments about 'Management of aspergillosis in immunocompromised patients. Recommendations of Lille University Hospital--4th version--November 2004']. | Medecine et maladies infectieuses 20050601 |
| Successful treatment of disseminated Aspergillosis in a leukemic child. | Puerto Rico health sciences journal 20050601 |
| Caspofungin versus amphotericin B for candidemia: a pharmacoeconomic analysis. | Clinical therapeutics 20050601 |
| Hepatic uptake of the novel antifungal agent caspofungin. | Drug metabolism and disposition: the biological fate of chemicals 20050501 |
| Cerebral aspergillosis in the critically ill: two cases of successful medical treatment. | Intensive care medicine 20050501 |
| Successful treatment of disseminated aspergillosis with the combination of voriconazole, caspofungin, granulocyte transfusions, and surgery followed by allogeneic blood stem cell transplantation in a patient with primary failure of an autologous stem cell graft. | European journal of haematology 20050501 |
| Exposure of Candida albicans to antifungal agents affects expression of SAP2 and SAP9 secreted proteinase genes. | The Journal of antimicrobial chemotherapy 20050501 |
| Candida prosthetic valve endocarditis cured by caspofungin therapy without valve replacement. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050501 |
| A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20050501 |
| Characterization of Aspergillus fumigatus mutants with reduced susceptibility to caspofungin. | Medical mycology 20050501 |
| Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use study. | The Journal of infection 20050401 |
| Caspofungin for invasive fungal infections: combination treatment with liposomal amphotericin B in children undergoing hemopoietic stem cell transplantation. | Pediatric transplantation 20050401 |
| Candida tropicalis arthritis of the knee in a patient with acute lymphoblastic leukaemia: successful treatment with caspofungin. | Hong Kong medical journal = Xianggang yi xue za zhi 20050401 |
| Combination antifungal therapy for invasive aspergillosis. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050401 |
| Systemic aspergillosis with predominant genitourinary manifestations in an immunocompetent man: what we can learn from a disastrous follow-up. | Infection 20050401 |
| Candida glabrata endophthalmitis treated successfully with caspofungin. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050301 |
| Caspofungin: a new therapeutic option for fungal endocarditis. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20050301 |
| Caspofungin as treatment for Candida glabrata hip infection. | International journal of antimicrobial agents 20050301 |
| Efficacy of caspofungin in prophylaxis and treatment of an adult leukemic patient with invasive pulmonary aspergillosis in allogeneic stem cell transplantation. | Mycoses 20050301 |
| Caspofungin as second-line therapy for fever of unknown origin or invasive fungal infection following allogeneic stem cell transplantation. | Bone marrow transplantation 20050301 |
| Studies of the paradoxical effect of caspofungin at high drug concentrations. | Diagnostic microbiology and infectious disease 20050301 |
| In vitro activity of caspofungin compared to amphotericin B, fluconazole, and itraconazole against Candida strains isolated in a Turkish University Hospital. | Medical mycology 20050301 |
| Caspofungin versus liposomal amphotericin B for empirical therapy. | The New England journal of medicine 20050127 |
| Caspofungin versus liposomal amphotericin B for empirical therapy. | The New England journal of medicine 20050127 |
| Caspofungin versus liposomal amphotericin B for empirical therapy. | The New England journal of medicine 20050127 |
| Caspofungin versus liposomal amphotericin B for empirical therapy. | The New England journal of medicine 20050127 |
| Caspofungin versus liposomal amphotericin B for empirical therapy. | The New England journal of medicine 20050127 |
| Caspofungin versus liposomal amphotericin B for empirical therapy. | The New England journal of medicine 20050127 |
| [Caspofungin in the replacement of amphotericin B in the treatment of fungal diseases]. | Zhonghua yi xue za zhi 20050105 |
| Evaluation of Mycograb, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies. | Diagnostic microbiology and infectious disease 20050101 |
| Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. | American journal of ophthalmology 20050101 |
| New antifungal drugs and the pediatric cancer patient: current status of clinical development. | Klinische Padiatrie 20050101 |
| Caspofungin and amphotericin B for disseminated Fusarium verticillioides in leukemia. | The Annals of pharmacotherapy 20050101 |
| [Hepatosplenic and kidneys candidasis complicating an acute myeloblastic leukemia. A case treated with voriconazole and caspofungin]. | Annales de biologie clinique 20050101 |
| Hope for patients with neoplastic disease and invasive fungal infections. | The journal of supportive oncology 20050101 |
| Caspofungin: a review of its use in the treatment of fungal infections. | Drugs 20050101 |
| [Fungal peritonitis episodes in a peritoneal dialysis centre during a 10-year period: a report of 11 cases]. | Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20050101 |
| Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20041201 |
| Caspofungin therapy of neonates with invasive candidiasis. | The Pediatric infectious disease journal 20041201 |
| Antifungal resistance: the clinical front. | Oncology (Williston Park, N.Y.) 20041201 |
| Combinations of antifungal agents in therapy--what value are they? | The Journal of antimicrobial chemotherapy 20041101 |
| Pharmacokinetics/pharmacodynamics of echinocandins. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20041101 |
| In-vitro activity of nikkomycin Z alone and in combination with polyenes, triazoles or echinocandins against Aspergillus fumigatus. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20041101 |
| New type of effective antifungal treatment identified. | The Lancet. Oncology 20041101 |
| Use of newer antifungal therapies in clinical practice: what do the data tell us? | Oncology (Williston Park, N.Y.) 20041101 |
| Combination antifungal therapy: where are we now, and where are we going? | Oncology (Williston Park, N.Y.) 20041101 |
| Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity. | The Journal of infectious diseases 20041015 |
| Failure of caspofungin to treat brain abscesses secondary to Candida albicans prosthetic valve endocarditis. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20041015 |
| Refractory pulmonary aspergillosis treated with caspofungin after heart-lung transplantation. | Transplant international : official journal of the European Society for Organ Transplantation 20041001 |
| Disseminated mucormycosis associated with invasive pulmonary aspergillosis in a patient treated for post-transplant high-grade non-Hodgkin's lymphoma. | Leukemia & lymphoma 20041001 |
| Native valve endocarditis due to Candida glabrata treated without valvular replacement: a potential role for caspofungin in the induction and maintenance treatment. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20041001 |
| Caspofungin: a potential cause of reversible severe thrombocytopenia. | Pharmacotherapy 20041001 |
| Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. | The New England journal of medicine 20040930 |
| Antifungal therapy in patients with fever and neutropenia--more rational and less empirical? | The New England journal of medicine 20040930 |
| Combination antifungal therapy for invasive aspergillosis. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040915 |
| Combination therapy for invasive aspergillosis. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040915 |
| Echinocandins: ask not what they can do for esophageal candidiasis--ask what studies of esophageal candidiasis can do for them. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040915 |
| Use of the echinocandins (caspofungin) in the treatment of disseminated coccidioidomycosis in a renal transplant recipient. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040915 |
| Effects of caspofungin (MK-0991) and anidulafungin (LY303366) on phagocytosis, oxidative burst and killing of Candida albicans by human phagocytes. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20040901 |
| Efficacy and feasibility of aerosolized amphotericin B lipid complex therapy in caspofungin breakthrough pulmonary zygomycosis. | Bone marrow transplantation 20040901 |
| Retrospective study of the hepatic safety profile of patients concomitantly treated with caspofungin and cyclosporin A. | Transplant infectious disease : an official journal of the Transplantation Society 20040901 |
| [Study of in vitro activity of caspofungin on non-Candida albicans yeast strains determined by two methods: M27-A2 and EUCAST]. | Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20040901 |
| [New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin]. | Nederlands tijdschrift voor geneeskunde 20040821 |
| Trichosporon asahii infection treated with caspofungin combined with liposomal amphotericin B. | The Journal of antimicrobial chemotherapy 20040801 |
| Effects of several antifungal drug combinations against clinical and environmental isolates of Cryptococcus neoformans from China. | Mycoses 20040801 |
| Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections. | Bone marrow transplantation 20040701 |
| Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis. | European journal of haematology 20040701 |
| Treatment of meningeal coccidioidomycosis with caspofungin. | The Journal of antimicrobial chemotherapy 20040701 |
| Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient. | Annals of hematology 20040601 |
| Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet) in combination with caspofungin in experimental systemic aspergillosis. | Journal of pharmaceutical sciences 20040601 |
| Successful elimination of an invasive Aspergillus nidulans lung infection by voriconazole after failure of a combination of caspofungin and liposomal amphotericin B in a boy with chronic granulomatous disease. | The Pediatric infectious disease journal 20040601 |
| In vitro evaluation of cytochrome P450-mediated drug interactions between cytarabine, idarubicin, itraconazole and caspofungin. | Hematology (Amsterdam, Netherlands) 20040601 |
| [New antifungal agents and bronchopulmonary mycoses]. | Revue de pneumologie clinique 20040601 |
| Second-line therapy with caspofungin for mucosal or invasive candidiasis: results from the caspofungin compassionate-use study. | The Journal of antimicrobial chemotherapy 20040501 |
| Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease. | Bone marrow transplantation 20040501 |
| Differential effects of the combination of caspofungin and terbinafine against Candida albicans, Candida dubliniensis and Candida kefyr. | International journal of antimicrobial agents 20040501 |
| Compliance in two medical centers with criteria for use of caspofungin and lipid-based amphotericin B. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20040501 |
| Analysis of beta-1,3-glucan assembly in Saccharomyces cerevisiae using a synthetic interaction network and altered sensitivity to caspofungin. | Genetics 20040501 |
| Treatment of candidal cholangitis with caspofungin therapy in a patient with a liver transplant: documentation of biliary excretion of caspofungin. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040401 |
| Caspofungin for Candida endocarditis. | The Pediatric infectious disease journal 20040401 |
| New options for the treatment of invasive fungal infections. | Seminars in oncology 20040401 |
| Successful treatment of chronic disseminated candidiasis with caspofungin and itraconazole in a patient with progressive acute leukemia and prolonged neutropenia. | International journal of hematology 20040401 |
| Caspofungin modulates in vitro adherence of Candida albicans to plastic coated with extracellular matrix proteins. | The Journal of antimicrobial chemotherapy 20040301 |
| Caspofungin in a pediatric patient with persistent candidemia. | Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 20040301 |
| Caspofungin--a new therapeutic option for oropharyngeal candidiasis. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20040301 |
| Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogeneic bone marrow transplant. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20040301 |
| Newer antifungal agents. | Indian journal of pediatrics 20040301 |
| Deep sinus aspergillosis in a liver transplant recipient successfully treated with a combination of caspofungin and voriconazole. | Transplant infectious disease : an official journal of the Transplantation Society 20040301 |
| Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients. | The Journal of infection 20040101 |
| [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections. | Drug and therapeutics bulletin 20040101 |
| Clinical impact of the fungicidal activity of caspofungin administered alone or in combination in critically ill patients with severe abdominal candidiasis refractory to conventional antifungal drugs: case studies and critical review of the problem. | Acta clinica Belgica 20040101 |
| [In vitro activity of caspofungin against fluconazole-resistant Candida isolates from patients with HIV infection]. | Enfermedades infecciosas y microbiologia clinica 20040101 |
| An advanced double column-switching technique (LC-LC) for liquid chromatography/electrospray ionisation tandem mass spectrometry for fully automated analysis of caspofungin. | Rapid communications in mass spectrometry : RCM 20040101 |
| [Treatment with caspofungin of Candida tropicalis endocarditis resistant to fluconazol]. | Medicina 20040101 |
| [Drugs used in prophylaxis and treatment of fungal infections in immunosuppressed children]. | Przeglad lekarski 20040101 |
| Comment: caspofungin acetate for treatment of invasive fungal infections. | The Annals of pharmacotherapy 20031201 |
| The yeast protein kinase C cell integrity pathway mediates tolerance to the antifungal drug caspofungin through activation of Slt2p mitogen-activated protein kinase signaling. | Eukaryotic cell 20031201 |
| Disseminated Aspergillus terreus infection arising from cutaneous inoculation treated with caspofungin. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20031201 |
| [New antifungal agents: voriconazole and caspofungin]. | Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20031201 |
| Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20031115 |
| Caspofungin salvage therapy in a neutropenic patient with probable invasive aspergillosis: a case report. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20031101 |
| Echinocandin antifungal drugs. | Lancet (London, England) 20031004 |
| [Caspofungin: indication in Candida albicans-induced severe sepsis?]. | Annales francaises d'anesthesie et de reanimation 20031001 |
| Sequential exposure of Aspergillus fumigatus to itraconazole and caspofungin: evidence of enhanced in vitro activity. | Diagnostic microbiology and infectious disease 20031001 |
| Antifungal pharmacotherapy for neonatal candidiasis. | Seminars in perinatology 20031001 |
| Successful treatment of an Aspergillus brain abscess with caspofungin: case report of a diabetic patient intolerant of amphotericin B. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20030901 |
| First reported use of caspofungin in an extremely low-birth-weight neonate. | The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 20030901 |
| [Invasive aspergillosis: clinical manifestations and treatment]. | Revista iberoamericana de micologia 20030901 |
| Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20030801 |
| Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. | Journal of clinical microbiology 20030801 |
| Effects of amphotericin B and caspofungin on histamine expression. | Pharmacotherapy 20030801 |
| Retrospective study of the safety of caspofungin in immunocompromised pediatric patients. | The Pediatric infectious disease journal 20030801 |
| Caspofungin: the first in a new class of antifungal agents. | Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 20030801 |
| Cerebral phaeohyphomycosis in an immunodeficient child treated medically with combination antifungal therapy. | Medical mycology 20030801 |
| Caspofungin in combination with itraconazole and amphotericin B for the treatment of invasive Aspergillosis in humans, with a method to test ex vivo synergism. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20030801 |
| Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies. | Cancer 20030715 |
| Combination therapy with caspofungin and liposomal amphotericin B for invasive aspergillosis. | The Pediatric infectious disease journal 20030701 |
| New antifungal drugs and new clinical trials: interpreting results may be difficult. | Current opinion in oncology 20030701 |
| Update on antifungal therapy. | The Veterinary clinics of North America. Small animal practice 20030701 |
| New antifungal agents. | Dermatologic clinics 20030701 |
| Efficacy of caspofungin combined with amphotericin B against azole-resistant Candida albicans. | The Journal of antimicrobial chemotherapy 20030601 |
| Differential activity of triazoles in two-drug combinations with the echinocandin caspofungin against Aspergillus fumigatus. | The Journal of antimicrobial chemotherapy 20030601 |
| Caspofungin. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20030601 |
| Caspofungin in the treatment of candidosis and aspergillosis. | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20030601 |
| Resolution of fungemia due to Fusarium species in a patient with acute leukemia treated with caspofungin. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20030515 |
| Caspofungin: first approved agent in a new class of antifungals. | Expert opinion on pharmacotherapy 20030501 |
| Successful treatment of Candida krusei infection with caspofungin acetate: a new antifungal agent. | Critical care medicine 20030501 |
| The Candida albicans Cdr2p ATP-binding cassette (ABC) transporter confers resistance to caspofungin. | Molecular microbiology 20030401 |
| Comment: caspofungin acetate for treatment of invasive fungal infections. | The Annals of pharmacotherapy 20030401 |
| Successful treatment of subcutaneously disseminated aspergillosis with caspofungin acetate in an allogeneic peripheral blood stem cell transplantation patient. | Haematologica 20030401 |
| Caspofungin versus amphotericin B for invasive candidiasis. | The New England journal of medicine 20030327 |
| In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates. | Antimicrobial agents and chemotherapy 20030301 |
| Caspofungin: the first representative of a new antifungal class. | The Journal of antimicrobial chemotherapy 20030301 |
| Caspofungin in the treatment of oropharyngeal candidiasis. | International journal of clinical practice 20030301 |
| Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin. | Cancer 20030215 |
| Resolution of azole-resistant oesophageal candidiasis in an AIDS patient after treatment with caspofungin. | AIDS (London, England) 20030214 |
| Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species. | The Journal of antimicrobial chemotherapy 20030201 |
| Capofungin therapy for Aspergillus lung infection in a boy with chronic granulomatous disease. | The Pediatric infectious disease journal 20030201 |
| In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp. | Diagnostic microbiology and infectious disease 20030201 |
| [Antifungal drug]. | Nihon rinsho. Japanese journal of clinical medicine 20030201 |
| Adding 2% glucose to culture media does not influence the activity of caspofungin against Candida species. | The Journal of antimicrobial chemotherapy 20030101 |
| Caspofungin acetate for treatment of invasive fungal infections. | The Annals of pharmacotherapy 20030101 |
| [Clinical development of antimycotics. Medical challenges]. | Pharmazie in unserer Zeit 20030101 |
| [A silver lining on the horizon: new antimycotics]. | Pharmazie in unserer Zeit 20030101 |
| Microbial natural products as a source of antifungals. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20030101 |
| Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole. | Current medical research and opinion 20030101 |
| [New systemic antifungal drugs: mechanisms of action, drug interactions and side effects]. | Mycoses 20030101 |
| Caspofungin: a review of its use in oesophageal candidiasis, invasive candidiasis and invasive aspergillosis. | Drugs 20030101 |
| [Systemic antifungal agents]. | Enfermedades infecciosas y microbiologia clinica 20030101 |
| Co-administration of caspofungin and cyclosporine to a kidney transplant patient with pulmonary Aspergillus infection. | Scandinavian journal of infectious diseases 20030101 |
| CNS-aspergillosis: are there new treatment options? | Mycoses 20030101 |
| [New therapeutical options for pulmonary fungal infections in non-neutropenic ICU-patients]. | Mycoses 20030101 |
| Comparison of caspofungin and amphotericin B for invasive candidiasis. | The New England journal of medicine 20021219 |
| Echinocandins--an advance in the primary treatment of invasive candidiasis. | The New England journal of medicine 20021219 |
| [Clinical relevance of mechanisms of antifungal drug resistance in filamentous fungi]. | Enfermedades infecciosas y microbiologia clinica 20021201 |
| Caspofungin. | Drugs of today (Barcelona, Spain : 1998) 20021201 |
| Laboratory evaluation of new antifungal agents against rare and refractory mycoses. | Current opinion in infectious diseases 20021201 |
| Successful treatment with caspofungin of hepatosplenic candidiasis resistant to liposomal amphotericin B. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20021101 |
| Efficacy of caspofungin in the treatment of esophageal candidiasis resistant to fluconazole. | Journal of acquired immune deficiency syndromes (1999) 20021001 |
| The role of caspofungin and the echinocandins in the antifungal armamentarium. | Current opinion in investigational drugs (London, England : 2000) 20021001 |
| The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro. | Antimicrobial agents and chemotherapy 20020901 |
| Response and relapse rates of candidal esophagitis in HIV-infected patients treated with caspofungin. | AIDS research and human retroviruses 20020901 |
| A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis. | The American journal of medicine 20020901 |
| Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20020801 |
| Combined antifungal treatment of visceral mucormycosis with caspofungin and liposomal amphotericin B. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20020801 |
| Caspofungin versus amphotericin B for the treatment of Candidal esophagitis. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20020701 |
| New drugs, old drugs - dear drugs, cheap drugs. | Swiss medical weekly 20020615 |
| Resolution of multidrug-refractory oesophageal candidiasis in an AIDS patient after treatment with caspofungin. | AIDS (London, England) 20020614 |
| In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance. | Journal of clinical microbiology 20020601 |
| Amphotericin B-resistant Aspergillus flavus infection successfully treated with caspofungin, a novel antifungal agent. | Journal of the American Academy of Dermatology 20020601 |
| Progressive cutaneous hyalohyphomycosis due to Paecilomyces lilacinus: rapid response to treatment with caspofungin and itraconazole. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20020515 |
| Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY 303366) alone and in combination against Candida spp. and Crytococcus neoformans via time-kill methods. | Diagnostic microbiology and infectious disease 20020501 |
| Caspofungin in combination with itraconazole for the treatment of invasive aspergillosis in humans. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20020415 |
| [First echinocandin on the market. New type of antifungal against Aspergillus & Co]. | MMW Fortschritte der Medizin 20020409 |
| Moisture assay of an antifungal by near-infrared diffuse reflectance spectroscopy. | Journal of pharmaceutical and biomedical analysis 20020401 |
| New drugs 2002. Part II. | Nursing 20020401 |
| Caspofungin: an echinocandin antifungal agent. | Clinical therapeutics 20020301 |
| Safety and tolerability of caspofungin acetate in the treatment of fungal infections. | Transplant infectious disease : an official journal of the Transplantation Society 20020301 |
| New antifungal agents-treatment standards are beginning to grow old. | The Journal of antimicrobial chemotherapy 20020201 |
| Combination therapy with caspofungin and amphotericin B lipid complex. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20020101 |
| The first echinocandin: caspofungin. | Mycoses 20020101 |
| Clinical efficacy of echinocandin antifungals. | Current opinion in infectious diseases 20011201 |
| A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20011101 |
| The echinocandins, first novel class of antifungals in two decades: will they live up to their promise? | International journal of clinical practice 20011101 |
| Caspofungin acetate, bivalirudin. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20011001 |
| [Caspofungin. A new antimycotic agents from the echinocandin group]. | Medizinische Monatsschrift fur Pharmazeuten 20010901 |
| Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections. | Expert opinion on investigational drugs 20010801 |
| Caspofungin (Cancidas) for aspergillosis. | The Medical letter on drugs and therapeutics 20010709 |
| Determination of an echinocandin, MK-0991, in mammalian plasma by radioimmunoassay. | Journal of pharmaceutical and biomedical analysis 20010701 |
| Caspofungin acetate: an antifungal agent. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010701 |
| New type of antifungal approved for invasive aspergillosis. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010401 |
| Fungal treatment approved. | AIDS patient care and STDs 20010401 |
| Hitting a new target with echinocandins. Why chase something else? | Current opinion in investigational drugs (London, England : 2000) 20010401 |
| Update on antifungals targeted to the cell wall: focus on beta-1,3-glucan synthase inhibitors. | Expert opinion on investigational drugs 20010201 |
| In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates. | Antimicrobial agents and chemotherapy 20010101 |
| New drug fights invasive fungal infection. | FDA consumer 20010101 |
| Caspofungin. | Drugs 20010101 |
| Federal Drug Administration panel recommends approval of Cancidas, Merck's investigational antifungal drug. | The Journal of the Association of Nurses in AIDS Care : JANAC 20010101 |
| Pharmacological update on new infusion drugs. | Journal of infusion nursing : the official publication of the Infusion Nurses Society 20010101 |
| Caspofungin: the first of a new class of antifungal agents. | Cancer practice 20010101 |
| The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans. | The Journal of infectious diseases 20001201 |
| Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice. | Antimicrobial agents and chemotherapy 20000901 |
| Comparison of the echinocandin caspofungin with amphotericin B for treatment of histoplasmosis following pulmonary challenge in a murine model. | Antimicrobial agents and chemotherapy 20000701 |
| Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans. | Antimicrobial agents and chemotherapy 20000301 |
| In vitro activity of the new echinocandin antifungal, MK-0991, against common and uncommon clinical isolates of Candida species. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 19990401 |
| In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods. | Diagnostic microbiology and infectious disease 19990201 |
| Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. | Journal of clinical microbiology 19981001 |
| In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). | Antimicrobial agents and chemotherapy 19971101 |
| Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. | Antimicrobial agents and chemotherapy 19971101 |
| Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans. | Antimicrobial agents and chemotherapy 19970901 |
| Treatment of murine disseminated candidiasis with L-743,872. | Antimicrobial agents and chemotherapy 19970801 |
| In vitro activity of a new pneumocandin antifungal, L-743,872, against azole-susceptible and -resistant Candida species. | Antimicrobial agents and chemotherapy 19970701 |
| In vitro growth-inhibitory activity of pneumocandins L-733,560 and L-743,872 against putatively amphotericin B- and fluconazole-resistant Candida isolates: influence of assay conditions. | Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 19970101 |